Keywords: angiotech, gets, 25m, under, new, baxter, coseal
Angiotech gets $25M under new Baxter Coseal deal
Article | 03 April 2009
Canada's Angiotech Pharmaceuticals will receive $25.0 million from US health care firm Baxter International after completing an amended and restated distribution ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscribe now
for unlimited access to all articles
Subscriptions are £60 per month, pay as you go.
Find out more details.
Already a subscriber? Click here to log in
- Encouraging results with Sangamo's SB-728-T in HIV treatment
- Bristol-Myers' data on Yervoy and nivolumab causes a stir
- AstraZeneca plans to move three cancer drug candidates into Ph III
- Sanofi prepares for regulatory filing of MF candidate on positive JAKARTA study results
- Merck Serono Ph III trial of L-BLP25 fails endpoint in NSCLC
